April 2019 – Page 2 – Policy & Medicine

FDA Outlines Plans for Medical Devices with AI

FDA Defends Oversight of Generic Drugs

Oklahoma Medicaid Payment Reform: Success or Bust?

CMS Turns Focus to Transparency

SCOTUS Declines to Get Involved in Maryland Drug “Price Gouging” Law

DOJ Hits Three Companies with FCA Settlements for Co-Pay Assistance Kickbacks – Two Companies enter CIA’s

Duke Agrees to Pay $112.5 Million in False Claims Act Settlement Related to Scientific Research Misconduct

JAMA Article Outlines REMS Failure, Suggests Reforms

Imported Drugs from Canada? Maybe in Florida

HHS Inspector General Stepping Down Next Month